## **Core Concept**
The question tests the understanding of chronic obstructive pulmonary disease (COPD) and its various causes, particularly focusing on the role of genetics in early-onset COPD. COPD is characterized by airflow limitation, typically progressive and associated with an enhanced chronic inflammatory response in the airways and the lungs to noxious particles or gases. The hallmark of COPD is a reduction in the FEV1/FVC ratio to less than 70%.

## **Why the Correct Answer is Right**
The patient's presentation with shortness of breath, a history of smoking, and radiographic findings of hyperinflation, increased lucency of the lung fields, bullae, and emphysematous changes, along with a decreased FEV1/FVC ratio, are consistent with COPD. The key detail here is the young age of the patient and the presence of a family history of similar conditions. This pattern suggests a genetic component to his disease. **Alpha-1 antitrypsin deficiency** is a well-known genetic cause of COPD, particularly in individuals who are young, have a family history of lung disease, and present with emphysema.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, other causes of COPD such as smoking or environmental exposures do not usually present with a strong family history.
- **Option B:** Similarly, this option is not provided, but one might consider other lung diseases; however, the combination of lung function tests, imaging, and family history points more specifically to a diagnosis like alpha-1 antitrypsin deficiency.
- **Option C:** Without the specific details of option C, we can infer that any option not directly related to genetic causes of COPD or not fitting the clinical picture provided would be incorrect.
- **Option D:** Assuming option D does not relate to alpha-1 antitrypsin deficiency, it would be incorrect given the clinical scenario.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that **alpha-1 antitrypsin deficiency** can cause COPD in individuals without a significant smoking history, especially if they are young and have a family history of lung disease. Screening for alpha-1 antitrypsin deficiency is recommended in patients with COPD who are under 65 and have a minimal smoking history (< 20 pack-years). ## **Correct Answer:** .